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Abstract 
Nutrition status in hospitalized patients with COPD on non-invasive ventilation 
Sara Kvien Jensen, RD, LMNT CNSC 
Advisor: Corrine Hanson, PhD, RD, LMNT 
Background: Nutrition is an important aspect of critically ill hospitalized patient care but the lack 
of consistent nutritional guidelines for sub-critically ill patients with Chronic Obstructive 
Pulmonary Disease (COPD) requiring non-invasive positive pressure ventilation (NPPV) may be 
putting vulnerable patients at risk. Hand grip strength measurements are an emerging metric for 
nutritional status.  
Objective: The objective of this study is to determine if hospitalized patients with COPD on 
NPPV show a difference in handgrip strength as a marker of nutritional status than those 
hospitalized patients with COPD not requiring NPPV. 
Methods: This was a prospective observational study of 10 hospitalized patients not requiring 
NPPV (Group 1) and 5 hospitalized patients requiring NPPV (Group 2). 3 measurements of 
handgrip strength on the patient’s dominate hand were averaged every alternating day during 
hospitalization. Mineral status and physiological parameters were also recorded concurrently 
with handgrip strength collection.  
Results: The two groups were similar overall. Group 2 had a longer length of stay, averaging 5.2 
(±0.45) days, with group 1 averaging 3.2 (±0.63) days (p=0.001). Mineral status and physiological 
parameters between the groups were similar.  Group 1 had an average change in handgrip 
strength of 1.59 (±1.82) kg with group 2 having an average change of -1.08 (±1.22) kg (p=0.016). 
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Conclusion:  Hospitalized patients with COPD on NPPV may be at risk for a decline in nutritional 
status compared to those not requiring NPPV as shown by a significant difference in change in 
handgrip strength.  
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Chapter 1: Introduction 
When patients are admitted to the hospital for medical treatment, their care, including 
nutrition, is often guided by evidence based guidelines.  This is true of patients admitted to the 
intensive care unit (ICU) for mechanical ventilation; however, this may not always be the case 
for patients just a step down from being critically ill. Patients on non-invasive, pressure 
supported ventilation (BIPAP or CPAP) may not be considered critically ill, but are often still very 
sick. Frequently used to prevent mechanical ventilation, non-invasive measures of ventilation 
leave more open ended guidelines on how to treat patients. In the case of mechanical 
ventilation, starting enteral nutrition early, within 24-48 hours of admission to a critical care 
unit, is a well-accepted standard of practice1.  When it comes to non-invasive ventilation, the 
issue of how to provide appropriate nutrition care becomes a gray area. Specialized nutrition 
care is an important aspect of critical care, but the lack of consistent nutritional guidelines in 
sub-critically ill patients may be putting vulnerable patients at risk for developing or 
exacerbating malnutrition. Before best practices can be established, the background on the area 
of interest needs to be examined.  Measuring handgrip strengths is an emerging metric to 
quickly assess nutritional status.2, 3, 4 This study seeks to examine the nutritional status of 
hospitalized patients with Chronic Obstructive Pulmonary Disease (COPD) who required non-
invasive means of ventilation, including Bilevel Positive Airway Pressure (BIPAP) and Continuous 
Positive Airway Pressure (CPAP), by utilizing handgrip strength measurements. It is hypothesized 
that patients with COPD requiring non-invasive ventilation will show evidence of a greater 
decline in handgrip strength as a proxy for nutrition status compared to those with COPD who 
do not require non-invasive ventilation. 
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Chapter 2: Literature review 
Background 
 The need for assisted ventilation is often a main reason patients are admitted to ICU, 
but assisted ventilation as we know it today, is a fairly recent development.  A full history of 
mechanical ventilation has been described elsewhere, 5 the highlights are as follows.  
Until the 1960, much of the ventilation assistance was provided by negative-pressure 
ventilation machines, such as the “iron lung.”  Non-Invasive positive pressure machines 
in the form of bag and mask, and later bellow and mask, machines were available.  
Advances in technology, as well as ongoing complication of the “tank” style negative 
pressure ventilations led to a transition to positive pressure ventilation in the 1960s.  
Today, these non-invasive ventilation modalities commonly include Bilevel Positive 
Airway Pressure (BiPAP) or Continuous Positive Airway Pressure (CPAP). 
Invasive ventilation began to become available in the 1940-1950s.  At first, these 
machines were quite simple, with much of the monitoring done manually.  Over time, 
they have developed into the more sophisticated machines common in today’s ICU.  
 Much research has been conducted on the care of patient receiving invasive positive pressure 
ventilation due to the critical nature of providing this type of care.  These patients are 
monitored closely, with practice guidelines to provide evidence based patient care. 
COPD 
Chronic Obstructive Pulmonary Disease is a common cause of respiratory distress.   As 
reported by the American Lung Association, COPD is the third leading cause of death in the 
United States of America.6  This is especially important in the elderly population, as they are 
more prone to exacerbations of COPD.  In fact, approximately 65% of patients over age 65 
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discharged from hospitals were admitted with COPD exacerbations.6 Providing excellent 
evidence based care to these patients is important to provide better outcomes, including 
reduced re-admission rates and cost of care.6 
COPD is defined as the presence of airflow limitations and its severity is based on lung 
function tests utilizing spirometry. The airflow limitation for a diagnosis of COPD is often defined 
as a FEV1/FVC ratio of <0.70.
7 FEV1 is the volume that has been exhaled at the end of the first 
second of forced expiration and FVC, or Forced Vital Capacity, is the volume of air forcibly 
exhaled from the point of maximal inspiration. COPD is often measured in severity by using the 
Global Initiative for Chronic Obstructive Lung Disease or GOLD score.7 This score is calculated in 
the presence of an FEV1/FVC ratio of <0.70 and is based on post-broncholdilator FEV1.  Lung 
function tests would be conducted after the administration of an inhaled bronchodilator 
medication to reduce variability.7 For example, a GOLD score of 1 or Mild COPD would have a 
FEV1 that is ≥80% of the predicted value. A GOLD score of 2 or Moderate COPD would have a 
measurement of ≥50% but <80% predicted FEV1. A FEV1 ≥30% but <50% predicted FEV1 would 
be classified as a GOLD score of 3 or Severe COPD. Lastly, a FEV1 <30% would be classified as 
Very Severe or GOLD 4.7 Classification of the severity of COPD can help guide the care of the 
affected patients.  
Treatment for COPD exacerbation is aimed at providing adequate oxygenation, 
especially to prevent tissue acidosis associated with poor oxygenation.  This includes the use of 
medication to promote bronchodilation, corticosteroids, antibiotics, as well as oxygen therapy.  
There are various means by which oxygen can be provided to patients. This can range from 
simply supplementing extra oxygen, to pressure supported oxygenation, either through a mask 
of varying size (non-invasive positive pressure ventilation) to full mechanical ventilation.  Due to 
4 
 
 
the high morbidity and difficulty weaning from ventilation associated with mechanical 
ventilation, NPPV has been supported to be an alternative treatment.  A Cochrane review of 
NPPV supports its use as a primary treatment for exacerbations of COPD.8 NPPV should be 
started early to help promote positive outcomes, including preventing severe acidosis, reducing 
mortality, reducing the need for intubation, and decreasing treatment failure.8 NPPV has been 
supported as a way of treating respiratory failure with similar improvement in gas exchange as 
conventional ventilation, but with fewer serious complications (66% serious complications in the 
mechanical ventilation group versus 38% in the NPPV group). 9 
Nutrition in COPD 
Nutrition is an important factor for good health, and this is very much the case for 
patients with COPD.  Malnutrition has been shown to be very common in patients with COPD.10  
However it is difficult to quantify the prevalence of malnutrition in COPD as it varies depending 
on the population studied and method used to measure malnutrition.  Hunter, Carey, and Larsh 
found in 1981 that between 19-60% of patient with COPD may be considered malnourished.11 
The reason for this high prevalence of malnutrition is unclear.  Possible etiology for malnutrition 
in COPD ranges from increased inflammation12 to increased work of breathing,13   to increased 
catabolism from high doses of corticosteroids often used for treatment in COPD.14 Whatever the 
cause of malnutrition in COPD, it is definitely an issue that needs to be addressed, especially 
during acute exacerbations of COPD that result in hospitalization.  
In fact, nutrition status is such an important factor in COPD, that weight loss is 
considered a prognostic factor in COPD.  Patients with COPD who have a lower body mass index 
(BMI) have been shown to have a higher rate of mortality.15 Conversely, improving nutrition 
status and promoting weight gain has been shown to reverse the negative effects of low body 
weight in COPD.15 In fact, multiple studies have shown that nutrition intervention, mostly 
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through oral nutrition supplements, can improve outcomes in COPD.  Schols et al. (1998) 
demonstrated that nutrition intervention through oral nutrition supplementation improved 
survivability of COPD by promoting weight gain.15 Participants who gained >2kg in 8 weeks, 
when compared to a control with no weight gain, showed on multivariate analysis to be an 
independent predictor of survival over 48 months of follow up (p=0.01).15 Another study by 
Saudny-Unterberger et al. (1997) showed that patients with acute exacerbation of COPD whose 
diet was supplemented with an oral nutrition supplement demonstrated improved oral intake 
by an additional 10kcals/kg/day and a trend toward improved general well-being score (+11.96  
versus -10.25 for the control, p=0.066).  However, even with oral supplementation, patients in 
this study did not improve measures of muscle strength, and were shown, through nitrogen 
balance studies, to be in negative nitrogen balance.14 In order to promote better patient care for 
patients with chronic and acute COPD, the nutrition status of the patient needs to be taken into 
consideration, and improved if necessary. 
Nutritional requirements in COPD may be difficult to calculate.  The “gold standard” of 
indirect calorimetry is expensive and not always readily available all hospital settings.  An energy 
intake of 27-30kcals/kg, or about 140% basal energy expenditure with a protein intake of 
1.2g/kg has been show to maintain energy balance in patients with an acute exacerbation of 
COPD.16 However, energy and protein intakes above this level may be necessary to improve 
nutritional status.14, 16 This is especially important considering the high prevalence of 
malnutrition in COPD patients. 
Clearly, nutrition is an important part of the care of patients in respiratory distress, but 
there does not appear to be a consensus on how best to provide nutrition care to these 
patients.  Many studies done on the importance of nutrition support in COPD utilized only oral 
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nutrition supplements.12, 14, 15Another study did note, “As part of standard care, patients with 
consistently poor intake despite interventions with oral nutrition support were enterally or 
parenterally fed on 25% of eligible intake days.” 17 No distinction was made between patients 
who received enteral versus parenteral nutrition.  Of note, the same study found patients who 
were only fed orally were less likely to meet nutritional requirements than those who received 
enteral or parental nutrition.17 However, in order for patients to obtain oral intake on NPPV, 
they must be able to tolerate breaks off NPPV. 
If a patient is unable to obtain or maintain adequate nutritional intake from an oral diet, 
the next step is to consider nutrition support.  This is especially true of patients that may be 
unable to tolerate breaks off of NPPV to take oral intake.  The axiom, “If the gut works, use it,” is 
very appropriate to consider when determining if a patient should receive enteral or parenteral 
nutrition support.  Barring any other complications, many patients admitted with respiratory 
distress have working guts.  As mentioned previously, early enteral nutrition is part of standard 
therapy for patients who are invasively ventilated.  The American Society for Parenteral and 
Enteral Nutrition’s (ASPEN) Critical Care feeding guidelines supports the use of early enteral 
nutrition in critically ill patients.  In fact, guideline A4 states, “Enteral nutrition should be started 
early, within 24-48 hours of admission.” 1 The difficulty in applying these guidelines is how to 
define critical illness. Early enteral nutrition is commonly a part of patient care for invasively 
ventilated patients but not necessarily patients on non-invasive ventilation, who may still be 
considered critically ill.  A poster session by Digby,  D'Arsigny, and Parker (2012) detailing their 
observation of non-invasively ventilated critically ill patients in an Ontario Academic Centre 
showed significant gaps in the care provided to 32 patients on NPPV.18 This included gaps in 
nutrition care, including almost 22% of patient receiving no “enteral nutrition” when on NPPV 
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for greater than 24 hours.  Patients who did receive “enteral nutrition”, it was provided orally 
(n=18), via feeding tube (n=4), or a combination of both (n=3).18   
Physicians may be wary of oral or enteral feeding in NPPV.  Many patients may be made 
NPO (nil per os, i.e. nothing by mouth) due to the risk of aspiration. In a study on complications 
of non-invasive ventilation, discomfort  from the mask was the most common complication, 
occurring in 30-50% of patient.19  Aspiration is a very serious complication of NPPV and is 
reported to occur about 5% of the time.19 Factors thought to reduce the incidence of aspiration 
include patient selection and gastric drainage, when appropriate.  Of note, over-sedation can 
increase risk of aspiration, and care needs to be taken to ensure patients maintain the ability to 
protect their airways.19 Other strategies have been shown to reduce the incidence of aspiration, 
including simply maintaining the head of the bed above 30 degrees.20 If the patient is being 
provided with enteral nutrition, routine verification of tube placement, assessment of GI 
intolerance such as abdominal distention and excessive residuals, and removing enteral feeding 
tubes as soon as possible are other ways to reduce the risk of this complication.20 However 
there is very little research specifically demonstrating the safety of enteral nutrition provision on 
NPPV.  
Another often cited reason for not providing enteral nutrition to patients on NPPV is 
complications with the mask sealing.   One study did note nasogastric tube insertion, along with 
the pressure applied to the respiratory system, can lead to worse air leaks from the mask.  In 
this study, adaptors were used to facilitate the provision of enteral nutrition and improve 
patient comfort.21 Another study done by Antonelli, et al. (1998), also briefly mentions the use 
of a seal connector in the dome of non-invasive ventilation mask to reduce air leakage for 
patients with nasogastric tubes.9 However, this study does not delineate if the nasogastric tube 
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was used for enteral feeding or gastric decompression9.   Of note, the clinical guidelines 
provided by the Royal Children’s Hospital in Melbourne, Australia recommend the use of 
nasogastric or nasojejunal feeding tube for children on non-invasive ventilation.  These 
guidelines do note the increased risk of abdominal distention and risk of pressure area 
formation and leaks from the mask.22 Children’s nutritional needs vary from those of adults, but 
this does serve as a reminder of the importance of adequate nutrition in NPPV and the ability to 
provide enteral feeding to those on NPPV. More conclusive research on the safety and best 
practices for provided enteral nutrition to patients on NPPV are needed.  
Parenteral nutrition is another means of providing nutrition support to patients.  Due to 
the ease of administration, and perceived decreased risk of complications, cautious physicians 
may feel more comfortable providing parenteral nutrition to patients on non-invasive 
ventilation.   As noted in APSEN’s critical care feeding guideline A3: “Enteral Nutrition is the 
preferred route of feeding over Parenteral Nutrition for critical ill patients who require nutrition 
support therapy.” 1 Therefore, unless a patient has another complication prohibiting using the 
patient’s GI tract, enteral nutrition should at least be attempted before parenteral nutrition.  
Overall, ICU patients have better outcomes, including lower infectious complications, when 
early enteral nutrition is provided over parenteral nutrition.23 If a patient is unable to tolerate 
enteral feeding, ASPEN’s Critical Care feeding guideline B1 supports waiting 7 days in the 
previously well-nourished patient before initiating parenteral nutrition.1 However, guideline B2 
supports starting parenteral nutrition sooner in critically ill patients with evidence of protein-
calorie malnutrition .1 If used correctly, parenteral nutrition can be beneficial in providing 
adequate nutrition, but care does need to be taken to ensure the proper use of this therapy. 
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Hand grip strength dynamometry  
Hand grip strength dynamometry is gaining popularity as a means of assessing 
nutritional status.  ASPEN included handgrip strength as one of the six criteria for malnutrition in 
their consensus statement on Characteristic Recommendations for the Identification and 
Documentation of Adult Malnutrition (undernutrition).24 The inclusion of hand grip strength 
dynamometry as criteria for malnutrition only seeks to highlight its importance in assessing 
nutritional status. Using handgrip strength as a measure of nutrition status has been increasing 
in popularity in more recent years but has been considered for longer. Watters, Haffejee, 
Angorn, and Duffy discussed nutritional assessment utilizing hand grip dynamometry in 1985.4 
Nutritional status is a multifaceted condition and handgrip strength is often utilized as one of 
many criteria when looking at nutritional status.  In ASPEN’s consensus statements on 
malnutrition, two of the six malnutrition criteria must be present to diagnosis malnutrition.24  As 
more research emerges on this means of looking at nutritional status, there is data to support 
hand grip strengths as an independent predictor of nutritional status and change in nutritional 
status.2 Muscle function reacts early to nutrition deficiency which makes hand grip strength 
dynamometer useful in detecting more subtle changes in nutritional status.3 Due to its ease of 
execution and benefits in being utilized as a marker of nutritional status and outcome predictor, 
hand grip strength is being increasingly being used as an outcome variable in nutritional 
intervention studies.3 Additional outcomes handgrip strength is associated with include ICU-
acquired paresis (ICUAP) or extreme muscle weakness from critical illness and mortality.25 
Utilizing handgrip strength measurements is a simple way to look at nutritional status, 
functional status, and to predict outcomes in hospitalized patients.  
Handgrip strengths can be compared to standard values or as a change from baseline. 
The JAMAR® brand dynamometer is frequently utilized in research and is often considered the 
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gold standard.2,3,26 Baldwin, et al in 2013 showed handgrip dynamometry to have a standard of 
error of 2.8kg with a minimal detectable difference with a 95% confidence of 7.8kg in the right 
hand for critically ill patients26. In the left hand, these numbers were 4.5kg standard of error and 
12.5 minimal detectable differences at 95% confidence. In contrast, they showed healthy adults 
to have a standard of error of 2.0kg in the right hand, and 2.6kg in the left, with a minimal 
detectable difference at 95% confidence of 5.7kg in the right hand and 7.1kg in the left.26 
However, this is just one study’s findings. ASPEN’s malnutrition guidelines for hand grip strength 
in severe malnutrition states is defined as measurably reduced compared to the manufacturer 
guidelines.24 The JAMAR Hydraulic Hand Dynamometer brand defines measurably reduced as 
more than two standard deviations from the mean of their established normal values based on 
age, sex, and hand.27 While comparing a patient’s hand grip strength to the normal values can 
help to diagnosis malnutrition and be useful when only one measurement is available, 
measuring a change from baseline can show changes in nutritional status over time. 
Clearly, nutrition is important for patients receiving NPPV for respiratory distress but 
how these patients receive nutrition can vary greatly.   Protocols to support feeding patients on 
invasive ventilation are widely accepted for their ability to improve outcomes.  A consensus on 
feeding patients on non-invasive ventilation would likely have similar success.  Until this can be 
done, further research needs to be done on the safety and best practices for feeding patient’s 
on non-invasive ventilation. This study seeks to support this by starting to look at the nutritional 
status of hospitalized patients with COPD to determine if there is a difference in nutritional 
status between those requiring NPPV and those that do not. With the emergence of hand grip 
strength as an easy, reliable predictor of nutritional status, this will be utilized as the primary 
outcome.  
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Chapter 3: Methods and Procedures 
Approval 
Data for this study were collected at CHI Health Saint Elizabeth Hospital, a local, 
community based hospital. Institution Review Board (IRB) approval was obtained from the 
University of Nebraska Medical Center IRB and the Catholic Health Initiative (CHI) IRB.  
Permission for this study was also granted by the research council at CHI Health Saint Elizabeth 
Hospital. Following IRB and institutional approval, informed consent was obtained from the 
patients. 
Criteria 
Inclusion criteria were any adult patients ages 19 and over, admitted with COPD 
exacerbations. Patients with a history of recent major surgery, trauma, or burns were excluded.  
Also, patients with conditions that may alter nutritional status were excluded, including 
cirrhosis, uncontrolled diabetes (in ketosis or more than 2 blood sugars >400mg/dL), and chronic 
renal failure on dialysis. Patients were also excluded if they had a contraindication that would 
prevent peripheral muscle strength testing, including acute or preexisting neurological 
condition, or cognitive impairment to follow commands. Additional exclusion criteria included 
end of life cares and significant language barrier. Patients who were mechanically intubated on 
admission were excluded from the study to help narrow the population of the study. However, 
those patients that are admitted on NPPV but later require more aggressive respiratory support 
with mechanical ventilation were included.  
The participants in this study were classified into 2 groups. Group 1 includes all COPD 
patients who did not require non-invasive ventilation. Group 2 includes all COPD patient 
enrolled in the study who did require non-invasive ventilation.   
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Data Collection 
Demographic and anthropometric data was obtained from medical record review, 
including age, self-reported race, sex, height, weight, any change in weight in past 6 months, any 
change in weight during hospitalization, and BMI.  The primary nutritional status endpoint 
obtained was hand grip strength as measured by a JAMAR® Hydraulic Hand Dynamometer.  
Following the manufacturer’s instructions, measurements of hand grip strength were taken. 
Three measurements on the patient’s dominate hand were recorded. Primary measurements 
were taken within 24-48 hours of enrolling into the study, with subsequent measurements 
taken every alternative day, until the patient discharged. Hospital outcomes included length of 
duration on non-invasive ventilation, and if the patient was mechanically ventilated. Hospital 
stay and mortality were also collected.  Nutrition intervention was also collected including days 
patient was NPO while on NPPV, or if the patient received enteral or parenteral nutrition.  It was 
also noted if the patient was on steroids, and if they participated in physical therapy. 
Additional data was collected on the same day as the handgrip strength measurements. 
Routine lab values were also collected, as available.  These included visceral protein stores of 
total protein, serum albumin, and pre-albumin.  Measurements of mineral status were collected 
such as serum iron, sodium, and potassium. Physiological parameters including blood urea 
nitrogen (BUN), creatinine, and fasting (or morning) blood sugar were also recorded. 
Additionally, average respiratory rate was collected.  Average percent of recorded meal intake 
were also recorded. 
Statistical Analysis 
Initial goal for recruitment was 30 patients not requiring BiPAP or CPAP (Group 1) and 
30 patients requiring BiPAP or CPAP (Group 2). Based on previous literature,26 this goal was 
established to achieve 80% power to detect a difference of 2.07 kg between the null hypothesis 
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that both group mean changes in grip strength are 2.00 kg and the alternative hypothesis that 
the mean of group 2 (patients requiring BiPAP or CPAP) is 4.07 kg with known group standard 
deviations of 2.76 for each group and with a significance level (alpha) of 0.05 using a two-sided 
Mann-Whitney test assuming that the actual distribution is normal.  
 Normal values were based on the standard of the handgrip dynamometer, which have 
been described elsewhere.  These normal values vary based on age, sex, and hand.27 Due to this 
variance, it is not useful to compare the mean handgrips strengths between groups, as each 
group did have slight differences in age, sex, and dominate hand. Instead, the averages of the 3 
measurements for each patient were compared against the standard values. Average 
measurements were considered to be in the normal range if they fell within 2 standard 
deviations of the mean for that group. 
Statistical analysis was conducted utilizing Statistical Package for the Social Sciences 
(SPSS) software. Descriptive summaries were presented using means, standard deviations, 
ranges, frequencies, and percentages.  Continuous variables, specifically the change in grip 
strength over the hospital stay, were compared between the groups using a Mann-Whitney test.  
Categorical data, such as demographic information, was compared between the groups using 
Fisher’s Exact test.   All comparisons were conducted at the 0.05 level of significance. 
Chapter 5: Results 
Actual recruitment proved to be more difficult than anticipated. Initial estimates based 
on expert input anticipated enrolling 30 patients in each group within 3 months. However, 
patients were enrolled in the study for a 6 month period. 10 participants were enrolled in Group 
1 and 5 participants were enrolled in Group 2. Demographics of the groups are shown in Table 
1. Unfortunately, anticipate enrollment was not achieved due to a number of factors including 
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patient not meeting the inclusion criteria. Of the patients screened to be in the study, around 45 
did not meet the inclusion criteria. Many of the patients on NPPV in the hospital screened for 
and excluded from the study, required it due to exacerbations of Congestive Heart Failure (CHF) 
and did not have a diagnosis of COPD. Pneumonia, without any COPD, was also very common in 
the screened patients. Many of the patient’s screened that did have a diagnosis of COPD were 
also unable to participate due to cognitive reasons. COPD primarily affects the elderly and 
combined with oxygenation issues, confusion, inability to follow commands, or inability to sign 
one’s own consent was common in the population. Of those screened, 20 patients met the 
exclusion criteria. Additional reasons for exclusion included poorly controlled diabetes (blood 
sugar >400 on more than 1 occasion or in diabetic ketoacidosis) and recent, major surgery. A 
number of patients also declined to consent to be in the study; 9 of the 24 patients that met 
both the inclusion criteria and exclusion criteria declined to participate. This resulted in 63% of 
patients able to participate in the study actually consenting to participate in the study. COPD 
and being on NPPV can be very tiring, which was an often cited reason for not wanting to 
participate in this study.  Due to being unable to meet our enrollment goals, this study is unable 
to reach 80% power and thus will be considered a feasibility or pilot study for assessing 
nutritional status of COPD in hospitalized patient.  It may also be a useful feasibility study on 
taking measurements of handgrip strength in the hospital as a means of determining nutritional 
status. 
There were no statistically significant differences in the demographic variables between 
the two groups. Group 1 included slightly older participants, with an average of 71.9 (±10.2) 
years in the control group and average of 68.6 (±11.1) years in the experimental group (Table 1).  
The proportion of males and females were the same in the two groups, with slightly more male 
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participants in both groups (Table 1). All of the participants listed their ethnicity as white non-
Hispanic in their admission screening. Only 1 participate from group 1 was left handed. 
Table 1: Demographic data of COPD patients per group 
 
Anthropometrics between the two groups were compared.  Participants in group 2 were 
more likely to be obese with an average BMI of 44.2kg/m2 (Table 2). The average BMI in group 1 
was 25.7kg/m2 (Table 2).  When compared, there was a significant difference in BMI between 
the two groups (P=0.005) (Table 2). Out of the 10 participants in group 1, 3 reported significant 
weight loss prior to admission as opposed to none of the 5 participants in group 2 reporting any 
weight loss (Table 2). Of those that lost weight, the average amount lost with 4.33 (±1.37) kg 
with a range of 3.4-5.9kg lost (Table 2).  
 
  
 Group 1 
(N=10) 
Group 2 
(N=5) 
p-value 
Age 
     Mean (SD) 
 
71.9 (10.2) 
 
68.6 (11.1) 
P=.624 
Gender 
     Male 
     Female 
 
6 (60%) 
4 (40%) 
 
3 (60%) 
2 (40%) 
 
P=1.00 
Ethnicity  
     White non-Hispanic 
 
10 (100%) 
 
5 (100%) 
 
P=1.00 
Dominate hand 
     Right 
     Left 
 
9 (90%) 
1 (10%) 
 
5 (100%) 
0 
 
P=1.00 
16 
 
 
Table 2: Anthropometrics of COPD patients per group 
 Group  1 
Mean (SD) 
Group 2 
Mean (SD) 
Significance 
Height (cm) 175.5 (9.0) 164.1 (12.3)  
Weight (kg) 80.6 (29.4) 117.88 (18.4)  
BMI (kg/cm2) 
     Range 
25.7 (8.0) 
12.2-37.4 
44.2 (9.2) 
31.9-55.8 
P=0.005 
# of patients with 
weight loss. 
3 / 10 participants 0 / 5 Participants P=0.505 
If loss, amount lost? 
     Range 
4.33kg (1.37) 
3.4-5.9kg 
NA  
 
Additional data about the participants were collected. Steroids and having Physical 
Therapy could potentially cause differences in handgrip strength, so it was noted what patients 
utilized these therapies. Overall, there was no difference during the hospitalization in use of 
steroids or Physical Therapy between the two groups (p=1.00 and p=0.23, respectively) (Table 
3).  Average days patients were kept NPO were also collected. Only one patient in group 1 and 
one patient in group 2 were kept NPO for at least a day (Table 3). Overall, there was no 
difference in average days NPO between the groups (p=0.68) (Table 3).  Patients that required 
mechanical ventilation after failed initial conservative therapies were to be tracked, but no 
patient in either group required this (Table 3).   A marked difference between the groups was 
found in the average length of stay. Group 1 averaged 3.2 ±0.63 day and group 2 averaged 5.2 
±0.45 days in the hospital (p=0.001) (Table 3). Mortality was also tracked between the two 
groups, with no patients in either group succumbing to the disease process (Table 3). Used as a 
measure of severity of COPD, a GOLD Score was attempted to be tracked, but was unavailable 
on all the patients in the study. 
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Table 3: Additional COPD patient factors per group 
 Group 1 
N=10 
Group 2 
N=5 
p-value 
Steroids 9 (90%) 4 (80%) 1.00 
Physical Therapy 6 (60%) 5 (100%) P=0.23 
Days NPO 
     Mean (SD) 
0.2 (0.63) 0.2 (0.45) P=0.68 
Mechanical 
Ventilation 
0 (0%) 0 (0%) P=1.00 
LOS 
      Mean (SD)      
Range 
3.2 (0.63) 
 
2-4 days 
5.2 (0.45) 
 
5-6 days 
P=0.001 
Mortality 0 (0%) 0 (0%) P=1.00 
 
Additional lab values were tracked at each time point that handgrip strengths were 
measured. These lab values include total protein, albumin, pre-albumin, iron, sodium, 
potassium, blood urea nitrogen (BUN), creatinine, and blood sugar. Data were not available for 
every patient at each time point. As only 1 patient was available to complete three sets of 
handgrip strength measurement, mineral status and physiologic data is only available on 1 
patient in group 2 for the third measure. No patient had pre-albumin levels drawn at any time 
point during the study.  The only measurement with a difference between the 2 groups was Iron 
during the 2nd data collection. Group 1 averaged 10.88mg and group 2 averaged 13.57mg (Table 
4). All other lab values showed no difference between the two groups at any time point of data 
collection. Meal intakes, averaged of three meals per day, between the groups showed no 
difference (Table 4). Respirations per minute showed no difference between the two groups 
(Table 4). 
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Table 4: Biochemical, meal intakes, and physiological data of COPD patients per group at each 
time point 
 Group 1 
1st 
Measure 
Group 2 
1st 
Measure 
P-Value 
 
 
Group 1 
2nd 
Measure 
Group 2 
2nd 
Measure 
P-Value Group 2 
3rd 
Measure
* 
Total 
protein 
(g/dL) 
6.8 
N=6 
6.5 
N=4 
P=0.394 . 
N=0 
5.6 
N=1 
. . 
N=0 
Albumin 
(g/dL) 
3.53 
N=6 
3.08 
N=4 
P=0.199 . 
N=0 
3.1 
N=1 
. . 
N=0 
Pre-Albumin 
(mg/dL) 
. 
N=0 
. 
N=0 
. . 
N=0 
. 
N=0 
. . 
N=0 
Iron  
(g/dL) 
12.00 
N=10 
12.24 
N=5 
P=0.902 10.88 
N=6 
13.57 
N=3 
P=0.039 13.8 
N=1 
Sodium 
(mEq/L) 
138.6 
N=10 
142.6 
N=5 
P=0.109 140.4 
N=7 
144.5 
N=4 
P=0.182 143 
N=1 
Potassium 
(mEq/L) 
4.1 
N=10 
4.22 
N=5 
P=0.951 4.19 
N=7 
4.12 
N=4 
P=1.000 4.3 
N=1 
BUN 
(mg/dL) 
18.5 
N=10 
24 
N=5 
P=0.158 23.9 
N=7 
30.3 
N=4 
P=0.449 51 
N=1 
Creatinine 
(mg/dL) 
0.88 
N=10 
1.04 
N=5 
P=0.270 0.96 
N=7 
1.15 
N=4 
P=0.345 1.43 
N=1 
Blood 
Sugars 
(mg/dL) 
161 
N=10 
199 
N=5 
P=0.327 165 
N=7 
183 
N=4 
P=0.449 131 
N=1 
Meal Intakes 
(%) 
76 
N=9 
66 
N=5 
P=0.280 76 
N=9 
74 
N=4 
P=0.751 100 
N=1 
Respirations 
(breaths/ 
min) 
19.4 
N=9 
19.0 
N=5 
P=0.946 19.0 
N=9 
21.5 
N=4 
P=0.825 20 
N=1 
*No 3rd measurement was available for group 1. 
The change in handgrip strength was the primary measurement for this study. The first 
measure of handgrip strength was taken within 48 hours of admission, after consent was 
obtained. Subsequent measures were taken every two days after the initial measure. The 
average change in handgrip strength for group 1 was 1.59 (±1.82)kg, while the average change 
in handgrip strength of group 2 was -1.08 (±1.22)kg  (Table 5). Patients with COPD who require 
BIPAP (group 2) averaged a negative change in handgrip strength (Table 5). Simple statistical 
analysis using the Mann-Whitney test to compare the change in handgrip strength did meet the 
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criteria for significance with a p-value of 0.016 (Table 5).  Due to the limited sample size, 
attempts to control for confounding variables, such as the difference in length of hospital stay, 
by utilizing multiple regression was unable to be completed.  
Table 5: Average handgrip strength of COPD patients per group at each time point and overall 
change 
 Group  1 
     Mean  (SD) 
Group 2 
      Mean  (SD) 
Significance  
1st Average Handgrip 
Strength (kg) 
26.00 (9.09) 
N=10 
19.53 (9.05) 
N=5 
P=0.178 
2nd Average Handgrip 
Strength (kg) 
26.41 (8.86) 
N=9 
19.92 (8.98) 
N=4 
P=0. 440 
3rd Average Handgrip 
Strength (kg) 
- 
N=0 
25.67 (-) 
N=1 
- 
Change in handgrip 
strength (kg) 
1.59 (1.82) 
N=9 
-1.08 (1.22) 
N=4 
P=0.016 
 
Handgrip strengths for each time point were compared against normal values for 
handgrip strength. As previous described, the normal range is defined as within 2 standard 
deviations of the mean for the patient’s age, sex, and hand. Overall, most of the measurements 
in this study did fall into the normal range (Table 6). Only 1 patient from group 2 fell outside of 
the normal range during the second time point of testing (Table 6).  Only 1 patient was able to 
complete a third set of handgrip strength measurements, and the average did fall within the 
normal range. There appears to be no difference between the groups in regard to having 
handgrip strengths within the established normal range. 
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Table 6: Statistical analysis of handgrip strength measurements compared to normal values 
per group. 
 Group 1 Group 2  
1st measurement 
within 2 SD of normal 
Mean 
100% 
N=10 
100% 
N=5 
P=1.0 
2nd measurement 
within 2 SD of normal 
Mean 
100% 
N=9 
75% 
N=4 
P=0.31 
3rd measurement 
within 2 SD of normal 
mean 
- 100% 
N=1 
- 
Chapter 6: Discussion 
Demographics 
The demographics of the patients in this study are similar to the average patient with 
COPD in the region the study was conducted. Average age for both groups was over 65 years 
old, as is expected in a disease that typically affects older adults (Table 1). Overall, our patients 
tend to be over age 65, with slightly more males then females, which fits the usual 
demographics of COPD.6  All participants identified as Non-Hispanic, Caucasian (Table 1). As the 
data collection center location is in Lincoln, Nebraska, it is expected the demographics of 
participants to be similar to that of the city. Based on the most recent demographic data, 
Lincoln’s population is 81% non-Hispanic or Latino White.28 The rest of the population of Lincoln 
is 10% Hispanic or Latino, 5% African-American, about 2% Asian, about 2% identifying as two or 
more races, less than 2% American Indian or Alaskan native, and less than 1% as Native 
Hawaiian or other Pacific Islander.28 Overall, the demographics of the patient population were 
comparable to the expected population, and there was little difference between the groups.  
Anthropometrics 
One exception in this study to the expected population of COPD patients was the BMI of 
the participants. Being underweight is very common in COPD10,11,15,23 while these participants on 
average were overweight in group 1 with an average BMI of 25.7 (±8.0)kg/m2 and obese in 
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group 2 with an average BMI of 44.2 (±9.2)kg/m2. The difference in weight may have been 
related to the participants in group 1 losing more weight prior to admit (Table 2). Weight loss is 
also very common in COPD10,11,15,23.. 
In contrast, average BMI found by Schols, et al. (1998) was 24.0kg/m2 in their 
retrospective study.15  A similar study on hospitalized patients with COPD by Thorsdottir and 
Gunnarsdottir (2002) reported BMI of the patient’s in the study (n=10) and while the average 
was not published, it was calculated by this author to average 23.8kg/m2.16 In correlation with 
this study, Reeves, et al. (2013) identified that hospitalized COPD patients with increasing BMI 
was a risk factor associated with less probability of meeting estimated energy and protein 
needs.   Average BMI in the Reeves’ study was 31.6 (±12.0).17 This study supports the same 
trend with group 2 having a higher average BMI and overall decreased in handgrip strength 
suggesting a decline in nutritional status.  
Loss of muscle mass is very common in COPD.  Even patients of a normal weight or 
overweight may have substantial depletion of muscle mass in COPD that is not readily 
apparent.23In another study conducted on hospitalized patients with COPD, mid-upper arm 
circumference was measured a test of lean body mass. Average mid-upper arm circumference 
was 21.18 ±2.31cm in males and 21.03±2.57cm in females (normal=27.4-35.5cm), showing 
significant decrease in all participants.10 With an average BMI of 19.38±3.1kg/m2 nearly all 
subjects in the lean body mass findings had low BMIs.10 
Additional participant data 
Additional data about this patient population was collected. Overall, little difference was 
noted between the two groups except for longer length of stay in group 2. Patients requiring 
NPPV tend to be sicker than those who do not require NPPV, so it is logical that group 2 has a 
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longer average length of stay in the hospital. Our data showed these patients had a longer 
length of stay by about 2 days (Table 3). Reported length of stay in other studies of acute 
hospitalized COPD patients is variable. One study gave a median length of stay as 24 days with a 
range of 2-48 days.17 Another study gave a range of 5-17 days for the control group and 8-33 
days for the treatment group; all patients were admitted to the hospital for COPD 
exacerbations.14 The longer length of stay for group 2 participants is significant as this may lead 
to greater healthcare cost.  
Use of steroids and physical therapy may affect handgrip strengths, but no difference 
was found between the 2 groups in these areas (Table 3). Days NPO can also affect nutritional 
status by limiting nutritional intake, but no difference in NPO days was found between the 
groups.  In fact, patients in both groups have very few average days NPO with only an average of 
0.2 days from both groups (Table 3).  No participants in the study required escalation of care to 
needing mechanical ventilation and there was also no mortality noted during the study (table 3).   
As a measure of COPD severity, GOLD status was attempted to be tracked, but was 
unavailable for every patient in the study. Conducting the lung function tests necessary to 
determine this GOLD score was likely a limiting factor. To the best of the author’s knowledge, 
this is consistent with the literature, as no reference to a GOLD score for measuring COPD 
severity was noted in the literature on nutrition status in COPD. Studies did utilize spirometry 
and other pulmonary functions tests as a measure of COPD exacerbation severity without 
calculating a GOLD score.10, 14, 15 One study did however utilize an APACHE (acute physiology and 
chronic health evaluation) score as a measure of disease severity.17 
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Biochemical and Physiological Data 
 Data on the mineral status and physiological lab values were recorded, as available, for 
each patient on the days handgrip strength was collected. Only 1 difference between the groups 
was found in average Iron status (hemoglobin) during the second set of measurements.  Of 
note, the lower iron average was in group 1 (table 4). Some of the lower average may be due to 
the lower number of data points available, so 1 low value may affect the overall average more. 
Not every patient had a second iron level drawn after admit, as evidence by the lower number 
of data points for both groups (N=6 for group 1 and N=3 for group 2). The study by Gupta, et al. 
in 2010 had similar collection of physiological and biochemical data that showed most 
biochemical data to be within normal range but physiological parameters on average were 
elevated.10 Average respiratory rate was given as 23.77±2.87 breathes/minute for males and 
23.33±2.33 breathes/minute for females with a normal value range of 14-18 breathes/minute.10 
Average respiratory rate found in this study ranged from 19.0-21.5 breathes/minute, which is 
also elevated compared to the normal values range 
Oral intake showed no difference between groups. This is important as oral intake is one 
of the six ASPEN malnutrition criteria24 and can play a large part of nutritional status. However, 
this study only recorded meal intakes as documented in the medical record. This does not take 
into account what the meal was, or if the intakes meet the patient’s estimated nutritional 
needs. Previous studies have shown that hospitalized COPD patients  have elevated nutritional 
needs, and would need to increase nutritional intake to above 140% basal energy expenditure 
and protein intake of 1.2 g/kg to promote improved nutritional status. 16 Further research 
comparing the nutritional intake of hospitalized patient with COPD non-requiring NPPV to those 
with COPD requiring NPPV may be beneficial.  
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Handgrip Strength 
Handgrip strength was the outcome of most interest in the study. Not every participant 
was able to complete more than 1 handgrip strength. Only 1 participant in group 2 was able to 
complete 3 handgrip strength measurements. While the limited sample size does not 
adequately power the study to support a strong conclusion, the data does suggest that there is a 
difference in change in handgrip strength between patients in the hospital with COPD requiring 
NPPV, and those in the hospital with COPD but not requiring NPPV(p=0.016) (Table 5).   The 
negative change in handgrip strength in patients with COPD who required BIPAP (group 2) 
suggests that their nutrition status may have declined over the course of their hospital 
admission especially when contrasted against the control group who overall saw an increase in 
handgrip strength. 
While there does appear to be a difference in change in handgrip strength of the two 
groups, the difference is small. Group 1 only showed an average change of 1.59kg while group 2 
showed an average change of -1.08kg. Both of these values are within the standard of error for 
handgrip strength found by Baldwin, et al. in 2013 for critically ill patients.26 The change is 
handgrip strength of both groups is also lower than the minimal detectable difference of critical 
ill patients from the same study.26   
Both groups did have a relatively short length of stay, with group 1 averaging just over 3 
days and group 2 only averaging just over 5 days (Table 3). It is possible that this time frame was 
not long enough to demonstrate differences in nutritional status. The ASPEN malnutrition 
criteria utilize a time frame of 5-7 days in the criteria for moderate or severe malnutrition in 
acute illness.24 With the exception of one participant in group 2, the rest of the participants did 
have average handgrips that were considered to be within the normal range (Table 6).  ASPEN’s 
criterion for severe malnutrition does include measurably reduced handgrip strengths, but that 
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is not criteria for moderate malnutrition.18 While the patients in this study may not meet the 
conditions for severe malnutrition, group 2 did show an average decrease in handgrip strength 
(Table 5).  
A study by Flood, et al. compared hand grip strength measurements as a means of 
measuring nutritional status to Patient Generated Subjective Global Assessment as a measure of 
nutritional assessment.2 Compared to this study, handgrip strength was measured after 2 weeks 
and was found to predict 42% of variability in change in nutrition status over time. 2 Flood, et al. 
suggested that handgrip strengths could predict changes in nutritional status earlier than 
Patient Generated Subjective Global Assessment and found handgrip strengths to independently 
predict nutritional status as well as change in nutritional status,2 supporting this study’s 
conclusion that the change in handgrip strength between the two groups demonstrates a 
difference in change in nutritional status.  
The results of this study suggest that care should be taken not to let these patients’ 
nutritional status, and thus handgrip strength, decrease further so they do not become severely 
malnourished. All in all, there does appear to be a difference between the control group that did 
not require NIPPV and the experimental group that did require NIPPV. 
Feasibility  
With the limited sample size of this study, one of the goals of the study was to 
determine the feasibility of utilizing hand grip strength as an outcome of nutritional status in 
COPD and patients on BIPAP. This is especially important considering the limited research in the 
literature specifically on hospitalized patient’s that require BIPAP. Overall, conducting the 
handgrip strength measurements was relatively simple.  All patients were able to complete the 
handgrip dynamometry test once enrolled in the study. The data also appears able to capture 
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the information needed.  Specifically this included if handgrip strength changed overtime and 
how measures of handgrip strength compared to normal values. The biggest obstacle 
encountered by this study was in the recruitment phase. A common barrier in research, this will 
likely still be a factor if additional studies of this type are conducted. However, there are 
strategies that may be helpful in minimizing this concern. Having a larger pool of participants to 
draw from, including utilizing a large hospital or having multiple centers may help to mitigate 
recruitment issues.  
Chapter 7: Conclusion 
Patient’s admitted to the hospital with COPD requiring NPPV may need more aggressive 
nutrition care than those who do not require NPPV. Handgrip strength is an emerging metric for 
assessing nutrition status, and the patient’s in group 2 that did require NPPV demonstrated a 
decline in handgrip strength compared to the control in group 1.This data supports the 
hypothesis that patients with COPD requiring non-invasive ventilation show evidence of a 
greater decline in handgrip strength as a proxy for nutrition status compared to those with 
COPD who do not require non-invasive ventilation. This study is limited in its scope, especially in 
regards to the limited sample size. More research is needed in this area to confirm these 
findings, as well as determine best practice guidelines for patient’s admitted with COPD who 
require NPPV but not mechanical ventilation.  
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